Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Finerenone”

71 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 71 results

Post-approval studies (Phase 4)Active Not RecruitingNCT05887817
What this trial is testing

Effects of Finerenone on Vascular Stiffness and Cardiorenal Biomarkers in T2D and CKD (FIVE-STAR)

Who this might be right for
Type 2 DiabetesChronic Kidney Diseases
Saga University 100
Not applicableStudy completedNCT04477707
What this trial is testing

A Study That Uses Data From Routine Eye Examinations of Patients Participating in Studies FIDELIO-DKD and FIGARO-DKD to Explore Whether Finerenone Can Delay the Progression of a Diabetes Complication That Affects the Eyes (Diabetic Retinopathy ,DR)

Who this might be right for
Diabetic Retinopathy
Bayer 206
Large-scale testing (Phase 3)Looking for participantsNCT07223502
What this trial is testing

A Study Comparing the Clinical Benefit of Finerenone Versus a Fixed Dose Combination (FDC) of Extended-Release Torsemide and Spironolactone in Patients With Hypertension and Chronic Kidney Disease

Who this might be right for
Hypertension (HTN)
Sarfez Pharmaceuticals, Inc. 30
Testing effectiveness (Phase 2)Study completedNCT01874431
What this trial is testing

Safety and Efficacy of Different Oral Doses of BAY94-8862 in Subjects With Type 2 Diabetes Mellitus and the Clinical Diagnosis of Diabetic Nephropathy

Who this might be right for
Diabetic Nephropathies
Bayer 823
Post-approval studies (Phase 4)Not Yet RecruitingNCT05814770
What this trial is testing

Comparing the Efficacy and Safety of Finerenone and Spironolactone in the Treatment of Primary Aldosteronism

Who this might be right for
Primary AldosteronismHypertension
The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School 96
Testing effectiveness (Phase 2)Study completedNCT01345656
What this trial is testing

BAY94-8862 Dose Finding Trial in Subjects With Chronic Heart Failure and Mild (Part A) or Moderate (Part B) Chronic Kidney Disease

Who this might be right for
Heart Failure
Bayer 457
Large-scale testing (Phase 3)Not Yet RecruitingNCT07181135
What this trial is testing

FINE-START: Efficacy and Safety of Finerenone in Patients With Chronic Kidney Disease Not Using Renin-angiotensin-system Inhibitors

Who this might be right for
Chronic Kidney Disease
University Medical Center Groningen 180
Not applicableLooking for participantsNCT07056595
What this trial is testing

Finerenone in Patients With IgA-nephropathy: Prospective Interventional Trial

Who this might be right for
IgA Nephropathy (IgAN)
Botkin Hospital 30
Not applicableNot Yet RecruitingNCT07326631
What this trial is testing

Finerenone for Cardiorenal Protection in Diabetic CKD: Impact on Renal Function Decline and Heart Failure

Who this might be right for
Diabetic Kidney Disease (DKD)Heart Failure
College of Physicians and Surgeons Pakistan 120
Not applicableStudy completedNCT06460987
What this trial is testing

Study of the Clinical Efficacy and Safety of Finerenone for the Treatment of IGA Nephropathy

Who this might be right for
FinerenoneIgA NephropathyProteinuria+1 more
The Fourth Affiliated Hospital of Zhejiang University School of Medicine 245
Large-scale testing (Phase 3)Study completedNCT02545049
What this trial is testing

Efficacy and Safety of Finerenone in Subjects With Type 2 Diabetes Mellitus and the Clinical Diagnosis of Diabetic Kidney Disease

Who this might be right for
Diabetic Kidney Disease
Bayer 7,352
Not applicableLooking for participantsNCT07232537
What this trial is testing

An Observational Study Called FINE-REAL Korea to Learn More About the Use of the Drug Finerenone in People With Chronic Kidney Disease and Type 2 Diabetes in a Routine Medical Care Setting in South Korea

Who this might be right for
Chronic Kidney DiseaseType 2 Diabetes Mellitus
Bayer 500
Not applicableActive Not RecruitingNCT06763146
What this trial is testing

An Observational Study to Learn More About How Safe Finerenone is and How Well it Works in Indian People With Chronic Kidney Disease and Type 2 Diabetes in Routine Medical Practice

Who this might be right for
Chronic Kidney DiseaseType 2 Diabetes Mellitus
Bayer 1,200
Early research (Phase 1)Study completedNCT01473108
What this trial is testing

Study to Investigate the Natriuretic Effects, Safety, Tolerability and Pharmacokinetics of BAY94-8862

Who this might be right for
Clinical Pharmacology
Bayer 67
Early research (Phase 1)Study completedNCT01687920
What this trial is testing

Dose Proportionality Study With BAY94-8862 IR (Immediate Release) Tablets

Who this might be right for
Heart Failure
Bayer 25
Large-scale testing (Phase 3)Not Yet RecruitingNCT07192952
What this trial is testing

Learn More About How Safe Finerenone is, When it is Taken for a Longer Time With Standard Treatment, in Children and Young Adults With Heart Failure and Left Ventricular Systolic Dysfunction

Who this might be right for
Left Ventricular Systolic DysfunctionHeart Failure (Pediatric)
Bayer 117
Post-approval studies (Phase 4)Study completedNCT06381323
What this trial is testing

The Clinical Efficacy and Safety of Finerenone in the Treatment of Primary Aldosteronism

Who this might be right for
Primary AldosteronismFinerenoneMineralocorticoid Receptor Antagonist
The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School 55
Post-approval studies (Phase 4)UnknownNCT06164379
What this trial is testing

Efficacy and Safety of Finerenone vs. Spironolactone in Patients With Primary Aldosteronism

Who this might be right for
Primary Aldosteronism
Shanghai Jiao Tong University School of Medicine 150
Testing effectiveness (Phase 2)Study completedNCT01955694
What this trial is testing

Phase IIb Safety and Efficacy Study of BAY94-8862 in Subjects With Worsening Chronic Heart Failure and Left Ventricular Systolic Dysfunction and Either Type 2 Diabetes Mellitus With or Without Chronic Kidney Disease or Moderate Chronic Kidney Disease Alone

Who this might be right for
Heart Failure
Bayer 72
Testing effectiveness (Phase 2)Looking for participantsNCT06835322
What this trial is testing

Effect of Finerenone in Patients With Non-diabetic Glomerulonephritis

Who this might be right for
Glomerulonephritis
Alexandria University 100
Load More Results